Search Within

Arielle Elkrief

Formats
  1. Journal Article (24)
  2. Meeting Abstract (14)
  3. Editorial (2)
  4. Review (2)
  5. Correspondence (1)
Groups
  1. GME, Medicine (43)
  2. Graduate Medical Education (43)
  3. Sloan Kettering Institute Postdocs (43)
  4. Department of Medicine (37)
  5. Solid Tumor Oncology Division (37)
  6. Thoracic Oncology (34)

More Groups

People
  1. Adam Schoenfeld (28)
  2. Marc Ladanyi (20)
  3. Matthew Hellmann (11)
  4. Charles Rudin (10)
  5. Gregory Riely (9)
  6. Hira Rizvi (9)

More People

Years
  1. 2025 (7)
  2. 2024 (10)
  3. 2023 (17)
  4. 2022 (7)
  5. 2021 (2)
Publications
  1. Journal of Thoracic Oncology (10)
  2. Journal of Clinical Oncology (9)
  3. Clinical Cancer Research (4)
  4. JCO Precision Oncology (4)
  5. Annals of Oncology (3)
  6. Journal for ImmunoTherapy of Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. Elsevier Inc. (11)
  3. American Association for Cancer Research (5)
  4. Oxford University Press (4)
  5. Biomed Central Ltd (2)
  6. Nature Publishing Group (2)

More Publishers

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC
    Journal Article

    Alessi, J. V.; Ricciuti, B.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; Elkrief, A.; Rodig, S. J.; Lebow, E. S.; Eicholz, J. E.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced NSCLC
    Journal Article

    Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Wang, X.; Cortellini, A.; Vaz, V. R.; Lamberti, G.; Frias, R. L.; Venkatraman, D.; Fulgenzi, C. A. M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Letter to the editor: Reply to Zhao, Wu, and Ma
    Correspondence

    Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Schoenfeld, A. J.; Awad, M. M.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Brief report: Combination of osimertinib and dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas
    Journal Article

    Elkrief, A.; Makhnin, A.; Moses, K. A.; Ahn, L. S.; Preeshagul, I. R.; Iqbal, A. N.; Hayes, S. A.; Plodkowski, A. J.; Paik, P. K.; Ladanyi, M.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance
    Journal Article

    Ogura, K.; Elkrief, A.; Bowman, A. S.; Koche, R. P.; de Stanchina, E.; Benayed, R.; Mauguen, A.; Mattar, M. S.; Khodos, I.; Meyers, P. A.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Impact of intratumoral microbiome on immunotherapy treatment outcomes in patients with advanced non-small cell lung cancer
    Meeting Abstract

    Elkrief, A.; Bowman, A.; Rizvi, H.; Hellmann, M.; Riely, G. J.; Schoenfeld, A. J.; Ladanyi, M.; Vanderbilt, C. M.
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Three-year outcomes and correlative analyses in patients with non–small cell lung cancer (NSCLC) and a very high PD-L1 tumor proportion score (TPS) ≥ 90% treated with first-line pembrolizumab
    Meeting Abstract

    Ricciuti, B.; Elkrief, A.; Alessi, J. V. M.; Wang, X.; de Castro Barrichello, A. P.; Pecci, F.; Lamberti, G.; Lindsay, J.; Sharma, B.; Felt, K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes of single-agent PD-(L)-1 versus combination with chemotherapy in patients with PD-L1-high (≥ 50%) lung cancer
    Meeting Abstract

    Elkrief, A.; Machado Alessi, J. V.; Ricciuti, B.; Rizvi, H.; Preeshagul, I. R.; Egger, J. V.; Chaft, J. E.; Rudin, C. M.; Riely, G. J.; Kris, M. G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS(G12D)-mutated non-small-cell lung cancer
    Journal Article

    Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Wang, X.; Cortellini, A.; Li, Y. Y.; Vaz, V. R.; Gupta, H.; Pecci, F.; Barrichello, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Alessi, J.; Elkrief, A.; Ricciuti, B.; Cortellini, A.; Wang, X.; Vaz, V. R.; Barrichello, A.; Lamberti, G.; Fulgenzi, C.; Pecci, F.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save